Cervical cancer differential diagnosis: Difference between revisions

	Cervical cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cervical Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cervical Cancer During Pregnancy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cervical cancer differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cervical cancer differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cervical cancer differential diagnosis
CDC on Cervical cancer differential diagnosis
Cervical cancer differential diagnosis in the news
Blogs on Cervical cancer differential diagnosis
Directions to Hospitals Treating Cervical cancer
Risk calculators and risk factors for Cervical cancer differential diagnosis

← Older edit Newer edit →

VisualWikitext

Revision as of 20:29, 24 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

Cervical cancer must be differentiated from other diseases that cause abnormal vaginal bleeding, such as cervical polyp, cervical leiomyoma, invasion of the cervix from primary uterine malignancy, vaginal cancer, cervical lymphoma, metastases to cervix, and cervical ectopic pregnancy.

Cervical cancer differential diagnosis

Cervical cancer must be differentiated from a mass involving the cervix, and causing abnormal vaginal bleeding:

Cervical polyp
Cervical leiomyoma
Cervical lymphoma
Cervical sarcoma

Metastases to the cervix
Cervical ectopic pregnancy
Cervical polyp
Cervicitis
Cervical erosion ( Ectropion )
IUD use
Pelvic inflammatory disease
Endometriosis
Adenomyosis
Postcoital bleeding
Clear cell adenocarcinoma

	Symptoms									Physical exam	Lab Findings				Imaging			Histopathology
Diseases	Clinical manifestations										Para-clinical findings								Gold standard	Additional findings
	Abnormal vaginal bleeding	Abnormal vaginal dyscharge	Pelvic pain or pressure	Itching or burning of the vulva	Vaginal/vulvar sores or change in color	Abdominal pain	Fever	Swollen lymph nodes	Weight loss	Gynecological examinations	HPV	Pap smear	STI Panel	Coagulation studies	Imaging 1	Imaging 2	Imaging 3	Histopathology
Cervical cancer			+	+
Cervical polyp	Postcoital bleeding Intermenstrual bleeding Postmenopausal bleeding
Cervical leiomyoma
Cervical lymphoma
Cervical sarcoma
Cervical erosion(Ectropion)
Cervicitis
IUD use
Pelvic inflammatory diseases
Endometriosis
Adnemyosis
Postcoital bleeding
DES exposure (Clear cell adenocarcinoma)
Paget's disease of vulva
Vaginal cancer

References

Template:WH Template:WS

@@ Line 26: / Line 26: @@
 |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
 ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
-| colspan="17" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
+| colspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
 ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
 | colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
 ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
 |-
-! colspan="14" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
+! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
-! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical exam
 ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
 ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
 ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
 |-
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Prolonged menstrual bleeding
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal bleeding
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Heavy menstrual bleeding
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Postcoital bleeding
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Premenopausal bleeding
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Postmenopausal bleeding
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Intermenstrual bleeding
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abnormal vaginal dyscharge
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain or pressure
@@ Line 51: / Line 46: @@
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Swollen lymph nodes
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Weight loss
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
+! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gynecological examinations
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |HPV
 ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pap smear
@@ Line 63: / Line 56: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical cancer
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
-| style="background: #F5F5F5; padding: 5px;" |+
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+| style="background: #F5F5F5; padding: 5px;" | +
+| style="background: #F5F5F5; padding: 5px;" | +
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 93: / Line 79: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical polyp
 | style="background: #F5F5F5; padding: 5px;" |
+* Postcoital bleeding
+* Intermenstrual bleeding
+* Postmenopausal bleeding
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 101: / Line 90: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 126: / Line 108: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical leiomyoma
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 155: / Line 130: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical lymphoma
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 184: / Line 152: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical sarcoma
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 213: / Line 174: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervical erosion(Ectropion)
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 242: / Line 196: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Cervicitis
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 271: / Line 218: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |IUD use
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 299: / Line 239: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pelvic inflammatory diseases
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 327: / Line 260: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Endometriosis
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 355: / Line 281: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Adnemyosis
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 383: / Line 302: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Postcoital bleeding
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 411: / Line 323: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |DES exposure (Clear cell adenocarcinoma)
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 439: / Line 344: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Paget's disease of vulva
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 467: / Line 365: @@
 |-
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vaginal cancer
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |

Cervical cancer differential diagnosis: Difference between revisions

Revision as of 20:29, 24 January 2019

Overview

Cervical cancer differential diagnosis

References

Navigation menu

Search